+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

S

Actively Recruiting

Researchers are studying cannabinoid hyperemesis syndrome CHS, a condition causing severe abdominal pain and vomiting in people who use cannabis regularly. This syndrome is hard to diagnose and often leads to repeated emergency room visits. The study aims to estimate how common CHS is among patients visiting adult emergency departments in Maine et Loire with abdominal pain or vomiting. It is a prospective, observational study involving multiple centers. The study includes patients aged 18 to 65 who visit an emergency department for abdominal pain or vomiting for the first time during the study period. Those who report using cannabis at least once a week for more than six months complete a questionnaire either online or on paper while in the emergency room. Patients identified with CHS will be followed up by telephone three months later to track symptom changes, recurrences, treatments, and cannabis use. Participants complete questionnaires during their emergency visit, providing information about their symptoms and cannabis use. For those with CHS, follow-up calls occur three months later to assess their health and treatment outcomes. Researchers will measure the number of patients diagnosed with CHS, their age and gender distribution, clinical features, cannabis use patterns, hospital treatments, and recurrence of symptoms. The study lasts 15 months, with a 12-month inclusion period and a 3-month follow-up for CHS patients.

Age: 18Years - 65YearsAll Genders
3 locations
S

Actively Recruiting

This research focuses on Philadelphia-negative myeloproliferative neoplasms MPNs, which are blood stem cell disorders causing excessive production of mature myeloid cells. These disorders include polycythemia vera, essential thrombocythemia, prefibrotic primary myelofibrosis, and primary myelofibrosis. The study aims to understand how monocytes and macrophages, important immune cells, contribute to the different features and progression of MPNs. Researchers want to explore their role because monocytes show altered functions in MPN patients and may influence disease outcomes. Participants will have their monocytes analyzed through blood samples to study specific cell signatures. These signatures include surface markers, cytokine profiles, and gene expression. The study will use these data to assess links between monocyte characteristics and genetic mutations, fibrosis levels, and disease prognosis over time. This evaluation will help clarify the involvement of immune cells in MPNs and may guide future targeted treatments. During the study, participants will provide blood samples for monocyte testing, and researchers will monitor disease features such as diagnosis classification and progression markers. The main outcome includes diagnosis according to WHO 2016 criteria, with follow-up assessments up to 24 months to track correlations between monocyte profiles and disease severity, mutations, fibrosis, and survival without disease worsening. This approach allows detailed observation of immune cell roles and clinical outcomes in MPN patients.

Age: 18Years +All GendersPhase Not Applicable
3 locations